Anticancer Effect of (S)-Crizotinib on Osteosarcoma Cells by Targeting MTH1 and Activating Reactive Oxygen Species
Anti-Cancer Drugs - United States
doi 10.1097/cad.0000000000000602
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2018
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)